EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities

Olga-Maria Iova, Gheorghe-Eduard Marin iD, Vlad Răzniceanu iD, Ștefania-Maria Mocrei-Rebrean iD, Sebastian Romeo Pintilie iD, Romana T Netea-Maier iD, Ioana Berindan-Neagoe iD

International Journal of Molecular Sciences · 17.06.2026 · 27 (12) · 5472

DOI: 10.3390/ijms27125472 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.06.2026. Verfasst von Olga-Maria Iova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Medicine and Pharmacy "Iuliu Hațieganu", 400023 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Warburg Effect, Oncologic, Thyroid Neoplasms. Die Arbeit nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitalization, Iuliu Hațieganu University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic thyroid carcinoma (ATC) represents the most aggressive thyroid malignancy, characterized by rapid progression, therapeutic resistance, and poor prognosis. Conventional treatments remain largely ineffective, highlighting the need for novel therapies. Metabolic reprogramming, particularly the Warburg effect (WE), has emerged as a promising area of investigation. This review synthesizes current evidence on the role of WE in ATC and PDTC, integrating data from molecular profiling, preclinical studies, and emerging therapeutic strategies. Oncogenic alterations frequently observed in ATC, including mutations in BRAF, RAS, TP53, and activation of PI3K/AKT/mTOR and HIF-1α signaling, converge to promote glycolytic reprogramming. This metabolic shift supports tumor proliferation, immune evasion, and metastasis through increased glucose uptake, lactate production, and microenvironmental remodeling. Key metabolic nodes, including glucose transporters, hexokinase, and monocarboxylate transporters, are regarded as promising targets. Preclinical studies suggest that pharmacological inhibition of these pathways reduces tumor growth, enhances radiosensitivity, and improves response to targeted therapies. Future efforts should focus on combination therapies, biomarker-driven patient stratification, and the development of targeted delivery systems to overcome toxicity and resistance. A deeper understanding of tumor metabolic heterogeneity will be essential for translating these approaches into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticWarburg Effect, OncologicThyroid NeoplasmsHumansMetabolic ReprogrammingAnimalsSignal TransductionMolecular Targeted TherapyGlycolysisAntineoplastic Agents

Stichwörter der Autor:innen

Warburg effectaerobic glycolysisanaplastic thyroid cancerlactate metabolismpoorly differentiated thyroid cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, University of Medicine and Pharmacy "Iuliu Hațieganu", 400023 Cluj-Napoca, Romania.
  • Department of Genomics, MEDFUTURE Institute for Biomedical Research, University of Medicine and Pharmacy "Iuliu Hațieganu", 400012 Cluj-Napoca, Romania.
  • Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Doctoral School, University of Medicine and Pharmacy "Iuliu Hațieganu", 400012 Cluj-Napoca, Romania.
  • Academy of Medical Sciences, 030167 Bucharest, Romania.

ORCID-Profile: Gheorghe-Eduard Marin, Vlad Răzniceanu, Ștefania-Maria Mocrei-Rebrean, Sebastian Romeo Pintilie, Romana T Netea-Maier, Ioana Berindan-Neagoe

Förderung

  • Ministry of Research, Innovation and Digitalization
  • Iuliu Hațieganu University of Medicine and Pharmacy

Zitieren

APA

Iova, O. M., Marin, G. E., Răzniceanu, V., Mocrei-Rebrean, Ș. M., Pintilie, S. R., Netea-Maier, R. T., & Berindan-Neagoe, I. (2026). Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities. International Journal of Molecular Sciences, 27(12), 5472. https://doi.org/10.3390/ijms27125472

Vancouver

Iova OM, Marin GE, Răzniceanu V, Mocrei-Rebrean ȘM, Pintilie SR, Netea-Maier RT, et al. Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities. International Journal of Molecular Sciences. 2026;27(12):5472. doi:10.3390/ijms27125472

BibTeX
@article{Iova2026,
  author = {Iova, Olga-Maria and Marin, Gheorghe-Eduard and Răzniceanu, Vlad and Mocrei-Rebrean, Ștefania-Maria and Pintilie, Sebastian Romeo and Netea-Maier, Romana T and Berindan-Neagoe, Ioana},
  title = {Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5472},
  doi = {10.3390/ijms27125472}
}
Kostenlos starten →